NCT01338610View on ClinicalTrials.gov

ESBA105 in Patients With Severe Dry Eye

PHASE2CompletedINTERVENTIONAL
Enrollment

334

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions
Eyes Dry Chronic
Interventions
BIOLOGICAL

ESBA105 ophthalmic solution

OTHER

ESBA105 vehicle

Inactive ingredients used as Run-In and placebo comparator

Trial Locations (1)

76134

Contact Alcon Call Center for Trial Locations, Fort Worth

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY

NCT01338610 - ESBA105 in Patients With Severe Dry Eye | Biotech Hunter | Biotech Hunter